Nogo-66 Receptor Antagonist Peptide (NEP1-40) Administration Promotes Functional Recovery and Axonal Growth After Lateral Funiculus Injury in the Adult Rat
Overview
Rehabilitation Medicine
Authors
Affiliations
Objective: The myelin protein Nogo inhibits axon regeneration by binding to its receptor (NgR) on axons. Intrathecal delivery of an NgR antagonist (NEP1-40) promotes growth of injured corticospinal axons and recovery of motor function following a dorsal hemisection. The authors used a similar design to examine recovery and repair after a lesion that interrupts the rubrospinal tract (RST).
Methods: Rats received a lateral funiculotomy at C4 and NEP1-40 or vehicle was delivered to the cervical spinal cord for 4 weeks. Outcome measures included motor and sensory tests and immunohistochemistry.
Results: Gait analysis showed recovery in the NEP1-40-treated group compared to operated controls, and a test of forelimb usage also showed a beneficial effect. The density of labeled RST axons increased ipsilaterally in the NEP1-40 group in the lateral funiculus rostral to the lesion and contralaterally in both gray and white matter. Thus, rubrospinal axons exhibited diminished dieback and/or growth up to the lesion site. This was accompanied by greater density of 5HT and calcitonin gene-related peptide axons adjacent to and into the lesion/matrix site in the NEP1-40 group.
Conclusions: NgR blockade after RST injury is associated with axonal growth and/or diminished dieback of severed RST axons up to but not into or beyond the lesion/matrix site, and growth of serotonergic and dorsal root axons adjacent to and into the lesion/matrix site. NgR blockade also supported partial recovery of function. The authors' results indicate that severed rubrospinal axons respond to NEP1-40 treatment but less robustly than corticospinal, raphe-spinal, or dorsal root axons.
Min Y, Yao H, Wang L, Cheng L, Hong E J Tradit Complement Med. 2023; 13(5):430-440.
PMID: 37693099 PMC: 10491986. DOI: 10.1016/j.jtcme.2023.03.006.
[Research progress on rodent models of cervical spinal cord injury].
Chen H, Rong X, Huang K, Liu H Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023; 37(1):120-126.
PMID: 36708125 PMC: 9883646. DOI: 10.7507/1002-1892.202209049.
Okimatsu S, Furuya T, Miura M, Shiratani Y, Yunde A, Inoue T Sci Rep. 2022; 12(1):14400.
PMID: 36002463 PMC: 9402533. DOI: 10.1038/s41598-022-14723-8.
Differences in the expression of myelopathy in a rat model of chronic spinal cord compression.
Miura M, Furuya T, Hashimoto M, Shiratani Y, Inoue T, Yunde A J Spinal Cord Med. 2022; 47(3):450-458.
PMID: 35993796 PMC: 11044740. DOI: 10.1080/10790268.2022.2111048.
Lee S, Schmit B, Kurpad S, Budde M J Neurotrauma. 2022; 39(23-24):1727-1740.
PMID: 35708112 PMC: 9734017. DOI: 10.1089/neu.2022.0034.